Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.

Identifieur interne : 001027 ( Main/Exploration ); précédent : 001026; suivant : 001028

Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.

Auteurs : D. Daily [Israël] ; A. Vlamis-Gardikas ; D. Offen ; L. Mittelman ; E. Melamed ; A. Holmgren ; A. Barzilai

Source :

RBID : pubmed:11290748

Descripteurs français

English descriptors

Abstract

Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.

DOI: 10.1074/jbc.M101400200
PubMed: 11290748


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</title>
<author>
<name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978</wicri:regionArea>
<wicri:noRegion>Tel Aviv 69978</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</author>
<author>
<name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
</author>
<author>
<name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
</author>
<author>
<name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author>
<name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
</author>
<author>
<name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11290748</idno>
<idno type="pmid">11290748</idno>
<idno type="doi">10.1074/jbc.M101400200</idno>
<idno type="wicri:Area/Main/Corpus">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001032</idno>
<idno type="wicri:Area/Main/Curation">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001032</idno>
<idno type="wicri:Area/Main/Exploration">001032</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</title>
<author>
<name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978</wicri:regionArea>
<wicri:noRegion>Tel Aviv 69978</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</author>
<author>
<name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
</author>
<author>
<name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
</author>
<author>
<name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author>
<name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
</author>
<author>
<name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
</author>
</analytic>
<series>
<title level="j">The Journal of biological chemistry</title>
<idno type="ISSN">0021-9258</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Animals, Newborn (MeSH)</term>
<term>Apoptosis (drug effects)</term>
<term>Bacterial Proteins (pharmacology)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Cerebellum (cytology)</term>
<term>Cerebellum (physiology)</term>
<term>Dopamine (pharmacology)</term>
<term>Enzyme Activation (MeSH)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Escherichia coli (MeSH)</term>
<term>Farnesol (analogs & derivatives)</term>
<term>Farnesol (pharmacology)</term>
<term>Glutaredoxins (MeSH)</term>
<term>JNK Mitogen-Activated Protein Kinases (MeSH)</term>
<term>MAP Kinase Signaling System (drug effects)</term>
<term>MAP Kinase Signaling System (physiology)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred BALB C (MeSH)</term>
<term>Mitogen-Activated Protein Kinases (metabolism)</term>
<term>Models, Neurological (MeSH)</term>
<term>NF-kappa B (metabolism)</term>
<term>Neurons (cytology)</term>
<term>Neurons (drug effects)</term>
<term>Neurons (physiology)</term>
<term>Oxidoreductases (MeSH)</term>
<term>Phosphatidylinositol 3-Kinases (metabolism)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protein-Serine-Threonine Kinases (MeSH)</term>
<term>Proteins (pharmacology)</term>
<term>Proto-Oncogene Proteins (metabolism)</term>
<term>Proto-Oncogene Proteins c-akt (MeSH)</term>
<term>Salicylates (pharmacology)</term>
<term>ras Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation enzymatique (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Animaux nouveau-nés (MeSH)</term>
<term>Antienzymes (pharmacologie)</term>
<term>Apoptose (effets des médicaments et des substances chimiques)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Cervelet (cytologie)</term>
<term>Cervelet (physiologie)</term>
<term>Dopamine (pharmacologie)</term>
<term>Escherichia coli (MeSH)</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Farnésol (analogues et dérivés)</term>
<term>Farnésol (pharmacologie)</term>
<term>Glutarédoxines (MeSH)</term>
<term>JNK Mitogen-Activated Protein Kinases (MeSH)</term>
<term>Mitogen-Activated Protein Kinases (métabolisme)</term>
<term>Modèles neurologiques (MeSH)</term>
<term>Neurones (cytologie)</term>
<term>Neurones (effets des médicaments et des substances chimiques)</term>
<term>Neurones (physiologie)</term>
<term>Oxidoreductases (MeSH)</term>
<term>Phosphatidylinositol 3-kinases (métabolisme)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protein-Serine-Threonine Kinases (MeSH)</term>
<term>Protéines (pharmacologie)</term>
<term>Protéines G ras (métabolisme)</term>
<term>Protéines bactériennes (pharmacologie)</term>
<term>Protéines proto-oncogènes (métabolisme)</term>
<term>Protéines proto-oncogènes c-akt (MeSH)</term>
<term>Salicylates (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée BALB C (MeSH)</term>
<term>Système de signalisation des MAP kinases (effets des médicaments et des substances chimiques)</term>
<term>Système de signalisation des MAP kinases (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Farnesol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Mitogen-Activated Protein Kinases</term>
<term>NF-kappa B</term>
<term>Phosphatidylinositol 3-Kinases</term>
<term>Proto-Oncogene Proteins</term>
<term>ras Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Bacterial Proteins</term>
<term>Dopamine</term>
<term>Enzyme Inhibitors</term>
<term>Farnesol</term>
<term>Proteins</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Farnésol</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Cervelet</term>
<term>Neurones</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Cerebellum</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Apoptosis</term>
<term>MAP Kinase Signaling System</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Apoptose</term>
<term>Neurones</term>
<term>Système de signalisation des MAP kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Facteur de transcription NF-kappa B</term>
<term>Mitogen-Activated Protein Kinases</term>
<term>Phosphatidylinositol 3-kinases</term>
<term>Protéines G ras</term>
<term>Protéines proto-oncogènes</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antienzymes</term>
<term>Dopamine</term>
<term>Farnésol</term>
<term>Protéines</term>
<term>Protéines bactériennes</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cervelet</term>
<term>Neurones</term>
<term>Système de signalisation des MAP kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Cerebellum</term>
<term>MAP Kinase Signaling System</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Animals, Newborn</term>
<term>Cells, Cultured</term>
<term>Enzyme Activation</term>
<term>Escherichia coli</term>
<term>Glutaredoxins</term>
<term>JNK Mitogen-Activated Protein Kinases</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Models, Neurological</term>
<term>Oxidoreductases</term>
<term>Phosphorylation</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>Proto-Oncogene Proteins c-akt</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation enzymatique</term>
<term>Animaux</term>
<term>Animaux nouveau-nés</term>
<term>Cellules cultivées</term>
<term>Escherichia coli</term>
<term>Glutarédoxines</term>
<term>JNK Mitogen-Activated Protein Kinases</term>
<term>Modèles neurologiques</term>
<term>Oxidoreductases</term>
<term>Phosphorylation</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>Protéines proto-oncogènes c-akt</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">11290748</PMID>
<DateCompleted>
<Year>2001</Year>
<Month>07</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0021-9258</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>276</Volume>
<Issue>24</Issue>
<PubDate>
<Year>2001</Year>
<Month>Jun</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J Biol Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</ArticleTitle>
<Pagination>
<MedlinePgn>21618-26</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Daily</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vlamis-Gardikas</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Offen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mittelman</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Melamed</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Holmgren</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Barzilai</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2001</Year>
<Month>04</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516009">Glrx2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012459">Salicylates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C093323">farnesylthiosalicylic acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4602-84-0</RegistryNumber>
<NameOfSubstance UI="D005204">Farnesol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048031">JNK Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="D018631">ras Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>VTD58H1Z2X</RegistryNumber>
<NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005204" MajorTopicYN="N">Farnesol</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D048031" MajorTopicYN="N">JNK Mitogen-Activated Protein Kinases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010088" MajorTopicYN="Y">Oxidoreductases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017346" MajorTopicYN="Y">Protein-Serine-Threonine Kinases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012459" MajorTopicYN="N">Salicylates</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018631" MajorTopicYN="N">ras Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2001</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2001</Year>
<Month>7</Month>
<Day>20</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2001</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">11290748</ArticleId>
<ArticleId IdType="doi">10.1074/jbc.M101400200</ArticleId>
<ArticleId IdType="pii">M101400200</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Israël</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
<name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
<name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
<name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
<name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
<name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</noCountry>
<country name="Israël">
<noRegion>
<name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001027 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001027 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:11290748
   |texte=   Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:11290748" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020